Previous close | 4.0300 |
Open | 4.0000 |
Bid | 2.8000 |
Ask | 6.1000 |
Strike | 40.00 |
Expiry date | 2024-12-20 |
Day's range | 4.0000 - 4.0000 |
Contract range | N/A |
Volume | |
Open interest | 14 |
We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Xenon Pharmaceuticals Inc. (NASDAQ:XENE) stands against the other mid-cap healthcare stocks. Global Healthcare Market: Growth Projections, Challenges, and Tech-Driven Innovations According to projections by ReportLinker, the market for healthcare […]
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Xenon's (XENE) clinical studies of azetukalner in epilepsy and other neurological disorders are progressing well. However, any setback is set to hurt the stock in the absence of a deep pipeline.